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ABSTRACT Human umbilical cord blood mesenchymal stem cells (hUCB-MSCs) are
used in tissue repair and regeneration; however, the mechanisms involved are not
well understood. We investigated the hair growth-promoting effects of hUCB-MSCs
treatment to determine whether hUCB-MSCs enhance the promotion of hair growth.
Furthermore, we attempted to identify the factors responsible for hair growth. The
effects of hUCB-MSCs on hair growth were investigated in vivo , and hUCB-MSCs advanced anagen onset and hair follicle neogeneration. We found that hUCB-MSCs coculture increased the viability and up-regulated hair induction-related proteins of
human dermal papilla cells (hDPCs) in vitro . A growth factor antibody array revealed
that secretory factors from hUCB-MSCs are related to hair growth. Insulin-like growth
factor binding protein-1 (IGFBP-1) and vascular endothelial growth factor (VEGF)
were increased in co-culture medium. Finally, we found that IGFBP-1, through the colocalization of an IGF-1 and IGFBP-1, had positive effects on cell viability; VEGF secretion; expression of alkaline phosphatase (ALP), CD133, and β-catenin; and formation
of hDPCs 3D spheroids. Taken together, these data suggest that hUCB-MSCs promote
hair growth via a paracrine mechanism.

#These authors contributed equally to
this work.

INTRODUCTION

provide only temporary improvement, and often with reduced effectiveness, which results in immediate hair loss [8-10]. Although
hair transplantation can replace the bald area with healthy hair,
it is an invasive surgery, and a sufficient number of hairs for replacement is not always available in patients with severe hair loss
[11]. Therefore, alternative therapeutic strategies are essential for
alopecia.
The hair follicle (HF) cycle includes the phases of growth (anagen), regression (catagen), and rest (telogen) [12]. The activity of
HFs can be influenced by the internal and external environments
[13]. The mature HF has a complex structure with multilayered,

Alopecia (hair loss) occurs due to many internal factors, such as
aging or hormonal balance disruption, as well as diverse diseases
and serious burns or wounds [1,2]. Hair loss is commonly accompanied by a region of thinned skin at the bald site [3,4]. Furthermore, these symptoms are due to the functional loss of follicular
stem cell activity (i.e., forming the hair follicles) [5]. Recently,
there have been numerous therapeutic trials of various treatments
for hair loss such as oral medications and hair transplantation
[6,7]. However, therapeutic drugs, like finasteride and dutasteride,
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concentric epithelial basement cylinders of keratinocytes and a
distinctive mesenchyme of human dermal papilla cells (hDPCs)
[14]. hDPCs are the main component of HFs and are widely studied as the key functional center responsible for controlling the
hair cycle throughout an animal’s life cycle [15]. The androgen
activators dihydrotestosterone and dickkopf-1, which can initiate damage-induced apoptosis of hDPCs, are some of the many
factors involved in androgenic alopecia, where the HF cycle is
incrementally arrested during the telogen phase and in which
scalp hair follicles are gradually replaced by smaller follicles [16,17].
Thus, hDPCs may play a pivotal role in the pathogenesis of alopecia.
Human umbilical cord blood-derived mesenchymal stem cells
(hUCB-MSCs) have been suggested to promote tissue repair and
have been used for tissue engineering in numerous studies [18,19].
Not only can their multiple lineages replace aged or damaged
cells, but their secretory factors can enhance tissue repair efficiency [20]. Human mesenchymal stem cells (hMSCs), which are
capable of self-renewal and differentiation into various mesenchymal tissues, including osteogenic, adipogenic, and chondrogenic
cell lineages, have been recognized as a promising tool for clinical
applications [21]. However, the secretion of soluble factors is one
of the key mechanisms underlying the therapeutic potential of
hUCB-MSCs recently shown to have therapeutic efficacy in various disease models [22,23]. Transplantation of ex vivo -expanded
hUCB-MSCs improved peripheral neuropathic pain [24] and
focal cerebral ischemia [25] in rats. Thus, the treatment model
of hUCB-MSC transplantation has been intensively studied for
currently-untreated tissue impairments [26].
Hair loss from an adult follicle is considered to be a permanent
state [27,28]. However, there are many therapeutic approaches
to overcome this irreversible outcome [29]. A previous study has
demonstrated that HF neo-genesis can be induced in wounds in
mice in an mIGF-1-dependent manner [30]. On other hand, hair
follicle stem cell differentiation is disturbed via inhibition of Wnt/
b-catenin [31]. The IGF-1/AKT/GSK3β/β-catenin signaling pathway is crucial for cell protection and tissue regeneration [32,33].
The use of IGF-1/AKT/GSK3β/β-catenin on hDPCs in hair regeneration is groundbreaking. In this study, we used hUCB-MSCs
to determine the effects of both stem cells and their paracrine
factors on reacquisition of hDPC conduction ability to induce
hair growth and to provide an effective therapeutic strategy for
alopecia.

METHODS
Animals
C3H/HeJ mice were obtained from Saeron Bio Inc. (Gyeonggido, Korea) and allowed to adapt for one week with free access
to food and water. The telogen-anagen transition model was inKorean J Physiol Pharmacol 2018;22(5):555-566
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duced by depilating the dorsal skin of mice in the telogen phase of
the hair cycle, as described previously [34]. Starting one day after
hair removal, minoxidill (3% v/w; Sigma-Aldrich; Merck KGaA,
Darmstadt, Germany) was topically applied to the minoxidill
group (MNX) for five days per week. At one day after hair removal, 400 µl of saline or hUCB-MSCs (1×105 cells/mice) were intradermally injected into multiple points (8 sites) in the skin of the
injection control and hUCB-MSC groups, respectively. The dorsal
skin was harvested for histological analysis at the end of the observation period (six weeks). The skin was then fixed in 4% formaldehyde and processed by paraffin block embedding using standard techniques to produce paraffin sections (10 µm thick). The
general histology was visualized using hematoxylin-eosin (HE)
staining. Immunohistochemistry was performed on sections
that had been steamed in 10 mM sodium citrate (pH 6.0, cat. no.
005000, Fisher Scientific, Inc., Waltham, MA, USA) for 15 min
prior to incubation with primary antibody. We used antibodies
directed against β-catenin (1:500, cat. no. 610153, BD Biosciences,
Franklin Lakes, NJ, USA). Primary antibodies were detected by
biotinylated secondary antibodies plus streptavidin-peroxidase
complex (cat. no. SA-5004, VECTOR LABORATORIES, INC.,
Burlingame, CA, USA) and brown FAST DAB staining (cat. no.
34002, Thermo Fisher Scientific, Inc., Waltham, MA, USA).
Counterstaining of sections was performed using hematoxylin
for DAB-stained sections light microscopy (DM750, Leica, Wetzlar, Germany). The protocol was approved by the medical ethics
committee of Chung-Ang University (Seoul, Korea).

Isolation and culture of hDPCs
hDPCs were purchased from Cefobio (Seoul, Korea) as primary
cells and were grown in Dulbecco’s modified Eagle’s medium
(DMEM; Invitrogen/Gibco-BRL, Grand Island, NY, USA) supplemented with 5% fetal bovine serum (FBS; Invitrogen/GibcoBRL) and 1% penicillin in a humidified environment. hDPCs in
the third or fourth passage were used.

Patch assay
The hair-inductive capacity of the hDPCs was assessed in accordance with the established patch assay [35]. Implantation was
performed as described previously [36]. Briefly, hUCB-MSCs (U)
were combined with freshly isolated neonatal mouse epidermal
(K) and dermal cells (D) and co-transplanted subcutaneously into
the skin on the backs of nude mice. The normal group, K plus D
group, K plus U, and K plus D plus U group were injected on the
same day. Two weeks later, skin samples were dissected from the
mice and examined to verify hair induction.

Culture of hUCB-MSCs
This study was approved by the Institutional Review Board of
https://doi.org/10.4196/kjpp.2018.22.5.555
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MEDIPOST Co., Ltd. Neonatal hUCB-MSCs were collected from
umbilical veins. Mononuclear cells were isolated from hUCB by
centrifugation on a Ficoll-Hypaque gradient (density: 1.077 g/cm3;
Sigma-Aldrich). The cells were then seeded at 5×105 cells/cm2 in
culture flasks. After colonies of spindle-shaped cells formed, the
cells were reseeded for expansion. hUCB-MSCs were cultured in
αMEM medium (Gibco; Thermo Fisher Scientific, Inc., Waltham,
MA, USA) supplemented with 10% FBS (Gibco) and gentamycin
(Gibco) in a humidified atmosphere containing 5% CO2 and 3%
O2 at 37°C. Cells were passaged when they reached 80% confluency and either used for experiments or redistributed to new culture plates. In all experiments, hUCB-MSCs used were at passage
6.

Human dermal papilla cell isolation and co-culture
with hUCB-MSCs
For co-culture experiments, 1×105 hDPCs were seeded into the
lower chamber of a 6-well transwell plate (Corning, New York,
NY, USA) containing co-culture medium (DMEM or MEM).
Immediately after the dermal papilla cells attached, the medium
was changed, and 2×105 hUCB-MSCs were placed into the upper
chamber. The plates were incubated at 37°C with 5% CO2 for the
indicated times before each analysis.

Cell proliferation assay
hDPCs were plated at a density of 1×105 cells/well in 6-well
plates and were continuously cultured for 120 h under each test
condition. At days 2 and 5 of co-culture with hUCB-MSCs, the
proliferation was measured using a WST-8 assay (Dojindo; Rockville, MD, USA). WST-8 solution (100 µL) was added to the cells
in 1 ml incomplete DMEM and incubated for 1 h at 37°C. The absorbance was then measured at 450 nm using a SpectraMax 190
microplate reader (Molecular Devices, Sunnyvale, CA, USA).

Alkaline phosphatase (ALP) activity
hDPCs were seeded at a density of 1×105 cells/mL in 6-well
plates. At days 2 and 5 of co-culture with hUCB-MSCs, ALP
activity of the hDPCs was determined enzymologically using an
ALP assay. After washing with 1X PBS, the cells were incubated
in 0.1 M NaNO3-Na2CO3 (Sigma-Aldrich) buffer containing 1%
(v/v) Triton X-100 (Sigma-Aldrich) and 2 mM MgSO4 (SigmaAldrich). Subsequently, 6 mM p-nitrophenyl phosphate (SigmaAldrich) was added as a substrate to each well and incubated for
30 minutes at 37°C. Finally, 1.5 M NaOH (Sigma-Aldrich) was
added to stop the enzyme-substrate reaction. Optical density (OD)
readings were performed at a wavelength of 405 nm using a SpectraMax 190 microplate reader (Molecular Devices, Sunnyvale,
CA, USA).

www.kjpp.net

Human growth factor and cytokine antibody array
The Raybio® Human Cytokine/Growth Factor Antibody array
I (RayBiotech, Norcross, GA, USA) was used to assay 23 cytokines
and 41 growth factors in the supernatants of the cell cultures. The
array membranes were incubated in blocking buffer for 30 min at
room temperature (RT), then 1 ml of conditioned medium from
either the hDPC, hUCB-MSCs, or hDPC plus hUCB-MSCs group
was added per well, followed by incubation for 1 h at RT. The
membranes were washed five times in wash buffer at RT, a biotinconjugated antibody was added, and the membranes were incubated for 1–2 h at RT. The membranes were washed again, 2 ml
of HRP-conjugated streptavidin was added, and the membranes
were incubated for 2 h. Following incubation with detection buffer for 2 min, the luminescence was detected using the LAS 3000
chemiluminescence imaging system (Fujifilm Inc., Tokyo, Japan)
and analyzed by densitometry using ImageJ 1.44 software (National Institutes of Health, Bethesda, MD, USA).

ELISA
The levels of insulin-like growth factor-1 (cat. no. DG100, R&D
Systems, Minneapolis, MN, USA), insulin-like growth factor
binding protein-1 (cat. no. DGB100, R&D Systems), and vascular
endothelial growth factor (cat. no. DVE00, R&D Systems) in cell
culture supernatants were quantified using an immunoassay kit.
After each experiment, the collected medium was added to each
well and incubated at room temperature for 2 h. The protein expression level was determined according to the manufacturer’s
protocol, and absorbance was measured at 450 nm using a SpectraMax 190 microplate reader (Molecular Devices).

Western blot analysis
Western blotting was performed as previously described using
total protein obtained from hDPCs. Antibodies for phosphorylated-AKT (1:1000, cat. no. #9271, Cell Signaling Technology, Inc.,
Danvers, MA, USA), AKT (1:1000, cat. no. #4685, Cell Signaling
Technology, Inc.), phopholyrated-GSK3β (1:1000, cat. no. #9323,
Cell Signaling Technology, Inc), GSK3β (1:1000, cat. no. #12456,
Cell Signaling Technology, Inc.), β -catenin (1:1000, cat. no.
610153, BD Biosciences, Franklin Lakes, NJ, USA), proliferating
cell nuclear antigen (1:1000, cat. no. #13110, Cell Signaling Technology, Inc.), β-actin (1:1000, cat. no. sc-4778, Santa Cruz Biotechnology, Inc., Dallas, TX, USA), ALP (1:100, cat. no. SC-15065,
Santa Cruz), CD 133 (cat. no. NB120-16518, Novus Biologicals,
CO, USA) were used as the primary antibodies, and goat antirabbit (cat. no. BA-1000, VECTOR LABORATORIES, INC.) and
goat anti-mouse (HRP) (cat. no. BA-9200, VECTOR LABORATORIES, INC.) were used as the secondary antibodies (1:10000).
The blots were analyzed using densitometry with ImageJ 1.44
software (National Institutes of Health).
Korean J Physiol Pharmacol 2018;22(5):555-566
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Establishment of hDPC micro-tissues in 3D hanging
drop cultures
For 3D cell cultures, Perfecta3D Hanging Drop Plates (3D
Biomatrix Inc., Ann Arbor, MI, USA) were used according to the
manufacturer’s protocol. To test the effects of IGFBP-1 on hDPCs micro-tissue formation, the rhIGFBP-1 (cat. no. 871-B1-025,
R&D Systems) (+) group was treated with rhIGFBP-1 (100 ng/ml).
The size distribution of the resulting hDPCs micro tissues was
analyzed to determine the optimal culture conditions. All hDPCs were cultured in serum-free medium (DMEM), which was
changed every 2 days using a multichannel pipette. The morphology and diameter of the hDPC spheroids were recorded using a
reverse phase-contrast microscope (IX61 FL, Olympus Japan Co.)
for up to 5 days.

Immunofluorescence staining
Immunofluorescence staining in hDPCs was performed as
previously described [37]. Briefly, hDPCs were treated with
rhIGFBP-1 (100 ng/ml) for 2 days. The cells were fixed in 10%
neutral buffered formalin solution at room temperature for 30
minutes, permeabilized in 2.5% Tween 20 (cat. no. 9005-64-5,
Sigma-Aldrich) in PBS for 5 min, then incubated overnight at
4°C with anti-ALP (1:500, cat. no. SC-15065, Santa Cruz), anti-βcatenin (1:500, cat. no. BD610154, BD Biosciences), anti-CD 133
(cat. no. NB120-16518, Novus Biologicals, CO, USA), anti-IGF-1
(cat. no. SC-9013 Santa Cruz), or anti-IGFBP-1 (cat. no. sc25257,
Santa Cruz) primary antibody in blocking solution (1:1000). After
several washes with PBS containing 0.5% Triton X-100 and 0.5%
BSA, the hDPCs were incubated with anti-rabbit Cy2 (cat. no.
711-225-152, Jackson ImmunoResearch Inc., PA, USA) or anti–
mouse (cat. no. 715-165-150; Jackson ImmunoResearch Inc.) labeled secondary antibodies for 1 h at RT. Following nuclear staining with DAPI dye (Sigma-Aldrich), the fluorescence signals were
viewed using a Zeiss confocal laser microscope (LSM 700; Zeiss,
Heidelberg, Germany).

Statistical analysis
Significant differences were determined using Student’s t-test,
with p<0.05 considered to be statistically significant. All data are
presented as the mean±SEM.

RESULTS
hUCB-MSCs promote hair follicle cycling,
morphogenesis in vivo
To determine whether hUCB-MSCs promote the anagen hair
cycle, we injected hUCB-MSCs intra-dermally at multiple sites
Korean J Physiol Pharmacol 2018;22(5):555-566
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in depilated mouse dorsal skin. Saline injection and daily topical
treatments of 3% minoxidil were used as controls. We determined
the hair cycle stage by measuring the status of skin hair regrowth.
We found that, by 5 weeks of treatment, hUCB-MSCs caused
diffuse darkening of the dorsal skin, while the control groups
showed no significant changes (data not shown). At 6 weeks
of treatment, hair regrowth was complete in the hUCB-MSCs
group, and the tip of the hair shaft emerged through the epidermis. Although the dorsal skin in the minoxidil-treated group had
incomplete pigmentation and contained hairs in the early stage
of the hair cycle, the dorsal skin of the normal and saline-injected
groups retained large areas without anagen induction (Fig. 1A).
After 6 weeks of treatment, we harvested the dorsal skin for histological analysis, which indicated that the hUCB-MSCs promoted
the telogen-anagen transition (Fig. 1B). In particular, the hair follicles that were treated with hUCB-MSCs were transformed from
the telogen phase to the early- and middle-anagen phases at 6
weeks (Fig. 1B). Remarkably, the hUCB-MSCs group prematurely
reentered the anagen phase compared with the minoxidil-treated
group (Fig. 1B). Furthermore, IHC data revealed that expression of the β-catenin protein, which is a positive regulator of hair
growth, was up-regulated in the hUCB-MSCs group compared to
the other groups (Fig. 1C).
To verify how hUCB-MSCs affect hair follicle morphogenesis,
we implanted hUCB-MSCs (U) with epithelial stem cells (K) and
dermal stem cells (D) of neonatal mice into nude mouse. Mixed
U, K, and D exhibited increased hair follicle induction compared
to the K plus D group (Figs. 1D and E). Interestingly, the K plus U
group did not show hair follicle morphogenesis (Figs. 1D and E).
Collectively, hUCB-MSCs enhanced hair follicle morphogenesis,
represented as an increase of follicular neogenesis (Figs. 1D and E).

hUCB-MSCs increase cell viability and upregulate hair
induction-related proteins in hDPCs
Changes in the microbiological environment cause hDPCs to
lose their conduction ability to induce hair follicle formation in
humans. To study the effects of hUCB-MSCs on the viability and
characteristics of hDPCs, we estimated cell viability and ALP
activity. The effect of hUCB-MSCs on hDPC proliferation and
ALP activity was revealed using WST-8 and ALP-activity assays.
hUCB-MSCs co-culture enhanced hDPC proliferation (Fig. 2A)
and restored ALP activity, both of which are anagen markers of
the hair cycle in hDPCs in vitro (Fig. 2B) [38].
We further examined AKT/GSK3β/β-catenin pathway regulation and proliferating cell nuclear antigen (PCNA) expression.
Result revealed that protein expression of phosphorylated Akt
(Ser473), phosphorylated GSK3β (Ser9), β-catenin, and PCNA
was pronounced in the hDPCs plus hUCB-MSCs group compared to hDPCs only. These results indicate that β-catenin, AKT,
and GSK3β, which are proteins contained in the pathway related
to cell growth and proliferation, were up-regulated in hDPCs
https://doi.org/10.4196/kjpp.2018.22.5.555
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Fig. 1. The effects of hUCB-MSCs on induction of the hair cycle anagen stage
in mice. The dorsal skin of six-weekold male C3H/HeJ mice was shaved
and then injected with saline, treated
with topical application of 3% minoxidil
(MNX, 5 times per week), or injected
with hUCB-MSCs (1×105 cells/head) (A)
Gross images of hair regrowth in C3H/
HeJ mice treated with either saline, MNX,
or hUCB-MSCs at six weeks after shaving.
(B) Histological analysis of dorsal skin
samples from each group using H&E
staining. Scale bar, 100 μm (C) Immunohistochemistry, dorsal skin samples
from each group were stained with antiβ-catenin, Scale bar, 100 μm. (D) Patch
assay: at 2 weeks, the nude mice were
sacrificed, and newly generated hair follicles were counted. Scale bar, 1 mm. (E)
Bar graph showing the number of each
hair follicles as mean±SD. *p<0.05 vs. K
plus D group. **p<0.01, ***p<0.001 vs.
hDPCs alone.

by co-culture with hUCB-MSCs. We found that hUCB-MSCs
not only promoted expression of hair anagen-induction-related
proteins, but also upregulated the expression of PCNA in hDPCs
(Figs. 2C and D). These findings suggest that, in hDPCs, the viability and ALP activity related to anagen conduction ability can
be affected and repaired by hUCB-MSCs in vitro , and this effect
is mainly regulated by AKT/GSK3β/β-catenin signaling.

Growth factor production in hDPC cultures with
hUCB-MSCs
A screening of growth factor production was performed to
discover the mechanisms underlying hair anagen induction by
hUCB-MSCs. Culture media supernatants from hDPCs, hUCBMSCs, and hDPCs plus hUCB-MSCs were collected after 5 days
of culture and analyzed with an antibody array for 42 growth
factors. Although several factors were detected in the hDPC plus
hUCB-MSCs group, two growth factors were upregulated in the
medium of the hDPC plus hUCB-MSCs group compared to the
hDPC group (Figs. 3A and B). The hDPCs co-cultured in the
presence of hUCB-MSCs showed a considerably increased levels
of IGFBP-1 (about >1.25-fold) and VEGF (about >1.25-fold). Notably, IGFBP-1 was detected in the hUCB-MSCs-only group but less
in the hDPC-only group. VEGF was also detected in the hUCBwww.kjpp.net

MSCs groups, but there was no significant difference compared
to the hDPC-only group. In addition, secretion of IGFBP-2, -6,
and PDGF-AA were detected both in the hDPCs and hDPCs plus
hUCB-MSCs group, but there was no statistical significance to
the increase. In conclusion, it was confirmed that the secretory
source of IGFBP-1 is hUCB-MSCs.
The actions of IGFs are tightly modulated by a family of proteins called IGF-binding proteins (IGFBPs), of which IGFBP-1 to
-6 have been characterized [39]. We measured IGF-1 and IGFBP-1
concentrations in culture media with an ELISA assay. Consistently, IGFBP-1 was not detected in the hDPCs alone, but the hUCBMSCs and hDPC plus hUCB-MSCs group showed increased
IGFBP-1 level compared to hDPCs alone (Fig. 3C). Additionally,
VEGF concentration was detected in the hDPC alone group and
hUCB-MSCs alone group, but it was overwhelmingly upward in
the hDPC plus hUCB-MSCs compared to each alone group (Fig.
3D). These results suggest that the IGFBP-1 expression measured
by the growth factor array is primarily secreted by the hUCBMSCs, and this is related to VEGF concentration. In addition, we
measured IGF-1 concentration in the culture media to determine
the relationship between IGF-1 and IGFBP-1 expression. The
protein concentration of IGF-1 was decreased in the hDPC plus
hUCB-MSCs group compared to the hDPC group (Fig. 3E).

Korean J Physiol Pharmacol 2018;22(5):555-566
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Fig. 2. The effects of hUCB-MSCs on
cell viability, ALP activity, and AKT/
GSK3β/β-catenin pathway regulation of hDPCs. hDPCs were co-cultured
with hUCB-MSCs for 48 h or 120 h in
two types of culture media (DMEM and
MEM). (A) The cell viability was estimated
using a WST-8 assay. (B) ALP activity. (C)
Representative images of Western blot
protein assays for p-AKT, AKT, p-GSK3β,
GSK3β, β-catenin, and proliferating cell
nuclear antigen (PCNA) in dermal papilla cells. hDPCs and hUCB-MSCs were
seeded in 6-well transwell plates. After
48 h, the cell lysates were harvested for
Western blot assays. (D) Intensities of the
immunoreactive bands on the Western
blots as quantified by densitometric
analysis. For all graphs, the data is reported as mean±SD. *p<0.01, ***p<0.001 vs.
hDPCs alone.

IGFBP-1 affects dermal papilla cell viability and
promotes expression of diverse proteins related to
hair induction
IGFBP-1, which was confirmed as the main component secreted by hUCB-MSCs, was studied to explore its independent function. To investigate the effects of IGFBP-1 on hDPCs, we treated
hDPCs with recombinant human IGFBP-1 (rhIGFBP-1) protein
and measured cell viability and VEGF secretion. The results indicated that the viability of hDPCs was significantly increased at 48
h after rhIGFBP-1 treatment (rhIGFBP-1 concentration: 12.5-200
ng/ml) (Fig. 4A). Furthermore, VEGF secretion also increased in
an rhIGFBP-1 concentration-dependent manner in hDPCs (Fig.
4B). The expression of proteins related to hDPC conduction ability was confirmed by immunofluorescence in hDPCs. ALP and
CD133 staining were strong after rhIGFBP-1 treatment (100 ng/
ml) compared to the non-treatment group (rhIGFBP-1 (-)). Additionally, β-catenin expression and nuclear translocation were
increased in the rhIGFBP-1 (+) group (Fig. 4C). Western blot data
also revealed the upregulated protein expression of ALP, CD133,
non-phosphorylation-β-catenin (non-p-β-catenin, activation
Korean J Physiol Pharmacol 2018;22(5):555-566

form), and β-catenin in the rhIGFBP-1 (+) group (Fig. 4D). To investigate the characteristics of hDPCs regarding the transformation to spheres and hair induction structures, the 3D sphere formation velocity of hDPCs was tested by seeding them in hangingdrop 96-well plates. When the seeding density exceeded 0.25×104
cells in the hanging-drop 96-well plate, the rapid aggregation of
hDPC with a loose spheroid structure occurred on day 1, which
then changed to a compact circular sphere after 5 days of incubation (Fig. 4E). The diameters of the spheres were quantified using
phase contrast imaging on day 5. After seeding the hDPCs in
hanging-drop 96-well plates, hDPCs treated with rhIGFBP-1 (100
ng/mL) produced spheres with an approximate diameter of 200
µm, which was larger than the sizes in the rhIGFBP-1 (-) group,
at day 5. The maximum diameter of the rhIGFBP-1 (-) group was
approximately half that of the rhIGFBP-1 (+) group (Figs. 4E and
F). Collectively, these data support the idea that rhIGFBP-1 can
stimulate cell proliferation; increase secretion of VEGF and enhance expression of ALP, CD133, and β-catenin; and promote the
conduction ability to 3D tissue-like formation.
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Fig. 3. Growth factor secretion profiles
of hDPCs alone, hUCB-MSCs alone,
and hDPCs plus hUCB-MSCs. (A) Representative images of the growth factor
antibody array analysis in culture media
obtained at 48 h of growth in each
group. (B) Quantification of the cytokine
array analysis of the culture media as
the fold increase compared with hDPCs
alone. The protein concentration in
each culture media measured individual
protein with ELISA. (C) IGFBP-1, (D) VEGF,
and (E) IGF-1. Abbreviations are as follows: IGFBP-1, -2, and -6, insulin-like
growth factor binding protein-1, -2, and
-6; PDGF-AA, platelet-derived growth
Factor-AA; VEGF, vascular endothelial
growth factor; IGF-1, insulin-like growth
factor-1. The data are reported as mean±
SD. *p<0.05, **p<0.01, vs. hDPCs alone.

Effects of recombinant protein IGFBP-1 on colocalization of IGF-1 to dermal papilla cells
In previous reports, it was demonstrated that IGFBP-1 can act
either directly or indirectly in biological environments [40] and
form the complexes with IGF-1 [41]. We hypothesized that increased IGFBP-1 acts as a complex with IGF-1 in hDPCs. Therefore, we investigated the effects of rhIGFBP-1 treatment on the
expression of IGF-1 in hDPCs. The results showed that most IGF1 was co-localized with IGFBP-1, which was assumed to be the
main secretory protein of hUCB-MSCs (Fig. 5). Interestingly, the
protein expression of IGF-1 was slightly elevated in the rhIGFBP-1
(+) group compared to the rhIGFBP-1 (-) group (Fig. 5). These
results suggest that secreted IGFBP-1 in hUCB-MSCs co-locate
with IGF-1 and affects the expression of IGF-1 in hDPCs.

DISCUSSION
Alopecia is a serious dermatological disease that occurs due to
diverse reasons [42]. Genetic factors and age have typically been
considered the main causes of hair loss [43]. Androgenic alopecia
results in decreased viability of dermal papilla cells and other cells
comprising hair follicle tissue [16]. Dermal papilla cells play a central role in follicular growth and differentiation and direct hair
www.kjpp.net

follicle cycling by secreting signaling factors to communicate to
root sheath cells [44]. The hair follicle cycle is affected by androgen and several other factors produced by stressful environments,
which cause a primary defect in hDPCs signaling, resulting in an
inability to initiate the hair follicular anagen phase [45,46]. Therefore, the restoration of hDPCs hair induction ability has been
considered a potential therapy for hair loss.
Mesenchymal stem cells (MSCs) exist as a heterogeneous
population in animals and have great potential for use in tissue
regeneration [47]. These MSCs are usually distinguished by their
shape, small size, and high nuclear fluctuation, which determine
their “stemness” and therapeutic capacity [48]. Attempts to regenerate tissue using biological factors secreted by UCB-MSCs have
recently been reported [49,50]. In a previous study, implantation
of BM-MSCs in normal and diabetic mice enhanced wound healing associated with increased angiogenesis [51]. In another study,
mesenchymal stem cell transplantation has beneficial results due
to its anti-inflammation potential in cardiac infarction damage
[52]. In addition, intravenous injection of hUCB-MSCs has a role
in the prevention of obesity as a mediator in macrophage polarization [53]. The effects of MSCs on tissue regeneration and antiinflammatory effects have been verified, and the functions and
main factors causing the therapeutic effects of MSCs have been
widely explored [54]. In this study, hUCB-MSCs triggered hair
anagen induction from the telogen phase in vivo . Furthermore,
Korean J Physiol Pharmacol 2018;22(5):555-566
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Fig. 4. The effects of recombinant
IGFBP-1 on hDPC viability, VEGF secretion, expression of proteins related
to hair anagen induction, and formation of 3D tissue-like structures of
hDPCs. (A) Cell viability. Control hDPCs
(Cont.) and IGFBP-1 (12.5-200 ng/ml)treated hDPCs were cultured for 48 h,
and the cell viability was measured using
an WST-8 assay. (B) VEGF concentration
in the culture media. Cont. and IGFBP-1
(12.5-200 ng/ml)-treated hDPCs were
cultured for 48 h. The culture media
was harvested, and VEGF concentration
was measured using an ELISA assay. (C)
Immunofluorescent staining of protein
ALP, CD133, and β-catenin in hDPCs.
rhIGFBP-1 (100 ng/ml) was administered
to hDPCs (1×105) for 48 h. The cells were
then stained to visualize the expression of anti-ALP, -CD133, and -β-catenin
(Green). Scale bar 5 µm. (D) Representative images of Western blot. Cell lysates
of hDPCs without or with rhIGFBP-1
(100 ng/mL) were immunoprobed with
anti-ALP, -CD133, non-p-β-catenin, and
β-catenin. Effect of rhIGFBP-1 (100 ng/
mL) on the formation of hDPC spheroids
after seeding for 5 days. (E) Representative images of passage 8-hDPCs from
each treatment group (n=4) aggregated
into microtissues in a regular manner
(0.25×104 cells/well, scale bar 200 µm).
(F) The bar graph shows the maximum
tissue diameter produced in each group
at Day 5. For all graphs, the data is shown
as mean±SD. **p<0.01, ***p<0.001, vs.
Cont. #p<0.01 vs. IGFBP (-).

hUCB-MSCs emphasized hair follicle morphogenesis, but in case
of ablation of the neonatal dermal cell, hUCB-MSCs and epithelial cells did not undergo hair follicle generation. We assumed that
hUCB-MSCs are not the main component of the newly generated
hair follicle and may play a role in assisting dermal cells to conduct tissue generation. These findings indicate that hUCB-MSCs
facilitate hair follicle regeneration and hair growth via a paracrine
mechanism. In a previous report, MSC-conditioned medium
that was modified to overexpress Wnt1a restored the hair cycle
in vivo [34]. In another study, BM-MSCs increased angiogenesis
in a diabetic mice wound model [51]. However, BM-MSCs were
located adjacent to the vasculature rather than in the vascular
walls [51]. This indicates that a paracrine effect of MSCs plays a
Korean J Physiol Pharmacol 2018;22(5):555-566

major role in angiogenesis and wound healing. In this study, we
demonstrated that hDPCs co-cultured with hUCB-MSCs in a detached environment had increased cell viability and ALP activity
and up-regulated the AKT/GSK3β/β-catenin pathway, indicating
that paracrine factors have a major role in recruitments of hDPC
conduction ability in vitro.
Insulin-like growth factor 1 (IGF-1) is an important growth
factor in many biological environments [55,56]. In a previous
report, it was found to have substantial structural homology with
insulin and influence food intake and glucose metabolism in
a similar manner to insulin [57]. Recently, IGF-1 has been suggested to play a crucial role in regulating cellular differentiation
and tissue generation during the development of hair follicles [58].
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Fig. 5. The effects of recombinant IGFBP-1 on the expression of IGF-1 on hDPCs via the co-localization of an IGF-1 and IGFBP-1. hDPCs (1×105
cells) were treated with rhIGFBP-1 (100 ng/mL) for 48 h and then stained with anti-IGF-1 (green), anti-IGFBP-1 (red), and DAPI (nucleus, blue). Scale bar
20 µm.

To exert its physiological effects, IGF-1 activates cells by binding
to specific cell-surface receptors [58]. In the circulatory system,
this biological factor mediates the endocrine action of growth
hormones on cellular growth and forms complexes with specific
binding proteins (BPs) [41].
There are six insulin-like growth factor binding proteins
(IGFBP-1~-6), which bind to IGF-1 and -2 with very high affinity
[41]. Because their affinity to IGFBP is 2- to 50-fold greater than
that of IGF-IR, these IGFBPs can modulate the distribution of
IGF among the proteins in interstitial fluids [41]. In this study,
we hypothesized that IGFBP-1 was be a major factor affecting
dermal papilla cells. We assumed that, since IGF-1 protein is the
autocrine factor of hDPCs bound to hDPCs with the assistance of
IGFBP-1, its concentration in culture media was decreased compared to that of the non-assisted group (hDPCs alone).
Cells within hDPCs and dermal sheath (DS) are specially identified as mesenchymal cells and express distinct enzymes and
molecules. Although the functions of most of these protein markers are not fully understood, they have been used to identify hDPCs and DS. The expression of some markers, like ALP and versican, correlates with hair inductive properties [59]. hDPCs easily
lose their characteristics and conductivity in vitro in the absence
of additional factors, such as WNT- or BMP-signaling [60]. In a
previous report, beta-catenin was upregulated in hDPCs, resulting in increased expression of the mesenchymal stem cell marker
CD133 [61]. Furthermore, this anagen-conductive protein is also
increased during the formation of hDPCs 3D tissue-like aggregates in vitro and in vivo [62]. In this study, rhIGFBP-1 not only
increased hDPCs viability and VEGF secretion, but also upregulated the protein expression of ALP, beta-catenin, and CD133.
In addition, rhIGFBP-1 enhanced the formation velocity of 3D
tissue-like aggregates of hDPCs in vitro . These results indicate
that IGFBP-1 has a positive role in maintaining cell longevity and
www.kjpp.net

regulating the conduction ability of hair anagen momentum.
IGFBPs can affect cells directly or indirectly and modulate the
function of IGF-1 in an endocrine, paracrine, or autocrine manner through IGF-1/IGFBP complexes [41]. In a previous report,
when IGFBP-1 and IGF-1 were added to porcine aortic smooth
muscle or human fibroblast cultures, the IGF-1/IGFBP-1 complex enhanced DNA synthesis compared to treatment with IGF1 alone [41]. Additionally, IGFBP-1 allowed IGF-1 to remain in
equilibrium with its high-affinity receptors for a prolonged interval [40,41]. In our results, rhIGFBP-1 formed a co-localization
with IGF-1. Notably, this result suggests that the IGF-1/IGFBP-1
co-localization facilitates the interaction of IGF-1 with its receptor in hDPCs during the progression of the cell cycle.
In this study, we demonstrated that hUCB-MSCs can accelerate the initiation of the hair follicle telogen-anagen transition,
increase the number of hairs in vivo , and enhance expression
of proteins related to hair induction in vitro . Notably, IGFBP-1
(assumed as the main secretory factor of hUCB-MSCs) restores
and promotes the hair-induction ability of hDPCs via an IGF-1/
IGFBP-1 co-localization. Taken together, our findings indicate
that hUCB-MSCs and their secretory protein IGFBP-1 can restore
the ability of hDPCs to induce hair follicle regeneration, potentially providing alternative therapeutic methods for alopecia. In
general, the immunosuppressive effect of the mesenchymal stem
cell treatment is well known, as mentioned above. The occurrence
of hair loss is also complex, and the immune response is one of its
major causes. We would need to further investigate the effects of
stem cell therapies on hair loss in a variety of biological environments.

Korean J Physiol Pharmacol 2018;22(5):555-566

564

ACKNOWLEDGEMENTS
This research was co-supported by the Global High-tech Biomedicine Technology Development Program of the National
Research Foundation (NRF) & Korea Health Industry Development Institute (KHIDI) funded by the Korean government
(MSIP&MOHW) (No. NRF-2015M3D6A1065114 and NRF2015M3D6A1065363) and by a Chung-Ang University Research
Scholarship grant in 2017.

CONFLICTS OF INTEREST
The authors declare no conflicts of interest.

REFERENCES
1. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in
women. J Clin Endocrinol Metab. 1961;21:1440-1447.
2. Harada T, Izaki S, Tsutsumi H, Kobayashi M, Kitamura K. Apoptosis of hair follicle cells in the second-degree burn wound unders
hypernatremic conditions. Burns. 1998;24:464-469.
3. Leyden J, Dunlap F, Miller B, Winters P, Lebwohl M, Hecker D,
Kraus S, Baldwin H, Shalita A, Draelos Z, Markou M, Thiboutot D,
Rapaport M, Kang S, Kelly T, Pariser D, Webster G, Hordinsky M,
Rietschel R, Katz HI, Terranella L, Best S, Round E, Waldstreicher
J. Finasteride in the treatment of men with frontal male pattern hair
loss. J Am Acad Dermatol. 1999;40:930-937.
4. Sinclair R. Male pattern androgenetic alopecia. BMJ. 1998;317:865869.
5. Kligman AM. Pathologic dynamics of human hair loss. I. Telogen
effuvium. Arch Dermatol. 1961;83:175-198.
6. Rogers NE, Avram MR. Medical treatments for male and female
pattern hair loss. J Am Acad Dermatol. 2008;59:547-566.
7. Leavitt M, Perez-Meza D, Rao NA, Barusco M, Kaufman KD, Ziering C. Effects of finasteride (1 mg) on hair transplant. Dermatol
Surg. 2005;31:1268-1276.
8. Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S. Minoxidil
use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2012;6:130-136.
9. Irwig MS, Kolukula S. Persistent sexual side effects of finasteride for
male pattern hair loss. J Sex Med. 2011;8:1747-1753.
10. Olsen EA, Hordinsky M, Whiting D, Stough D, Hobbs S, Ellis ML,
Wilson T, Rittmaster RS. The importance of dual 5alpha-reductase
inhibition in the treatment of male pattern hair loss: results of a
randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol. 2006;55:1014-1023.
11. Patwardhan N, Mysore V. Hair transplantation: standard guidelines
of care. Indian J Dermatol Venereol Leprol. 2008;74 Suppl:S46-53.
12. Alonso L, Fuchs E. The hair cycle. J Cell Sci. 2006;119:391-393.
13. Chueh SC, Lin SJ, Chen CC, Lei M, Wang LM, Widelitz R, Hughes
MW, Jiang TX, Chuong CM. Therapeutic strategy for hair regeneration: hair cycle activation, niche environment modulation, woundinduced follicle neogenesis, and stem cell engineering. Expert Opin
Korean J Physiol Pharmacol 2018;22(5):555-566

Bak DH et al

Biol Ther. 2013;13:377-391.
14. Harkey MR. Anatomy and physiology of hair. Forensic Sci Int.
1993;63:9-18.
15. Elliott K, Stephenson TJ, Messenger AG. Differences in hair follicle
dermal papilla volume are due to extracellular matrix volume and
cell number: implications for the control of hair follicle size and androgen responses. J Invest Dermatol. 1999;113:873-877.
16. Kwack MH, Sung YK, Chung EJ, Im SU, Ahn JS, Kim MK, Kim
JC. Dihydrotestosterone-inducible dickkopf 1 from balding dermal
papilla cells causes apoptosis in follicular keratinocytes. J Invest
Dermatol. 2008;128:262-269.
17. Dallob AL, Sadick NS, Unger W, Lipert S, Geissler LA, Gregoire
SL, Nguyen HH, Moore EC, Tanaka WK. The effect of finasteride,
a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. J Clin Endocrinol Metab. 1994;79:703-706.
18. El-Badri NS, Hakki A, Saporta S, Liang X, Madhusodanan S,
Willing AE, Sanberg CD, Sanberg PR. Cord blood mesenchymal
stem cells: Potential use in neurological disorders. Stem Cells Dev.
2006;15:497-506.
19. Chung JY, Song M, Ha CW, Kim JA, Lee CH, Park YB. Comparison
of articular cartilage repair with different hydrogel-human umbilical cord blood-derived mesenchymal stem cell composites in a rat
model. Stem Cell Res Ther. 2014;5:39.
20. Kim JY, Kim DH, Kim JH, Yang YS, Oh W, Lee EH, Chang JW.
Umbilical cord blood mesenchymal stem cells protect amyloid-β42
neurotoxicity via paracrine. World J Stem Cells. 2012;4:110-116.
21. Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U,
Choong C, Yang Z, Vemuri MC, Rao MS, Tanavde V. PDGF, TGFbeta, and FGF signaling is important for differentiation and growth
of mesenchymal stem cells (MSCs): transcriptional profiling can
identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood. 2008;112:295-307.
22. Seo Y, Yang SR, Jee MK, Joo EK, Roh KH, Seo MS, Han TH, Lee SY,
Ryu PD, Jung JW, Seo KW, Kang SK, Kang KS. Human umbilical
cord blood-derived mesenchymal stem cells protect against neuronal cell death and ameliorate motor deficits in Niemann Pick type
C1 mice. Cell Transplant. 2011;20:1033-1047.
23. Li XY, Zheng ZH, Li XY, Guo J, Zhang Y, Li H, Wang YW, Ren J,
Wu ZB. Treatment of foot disease in patients with type 2 diabetes
mellitus using human umbilical cord blood mesenchymal stem
cells: response and correction of immunological anomalies. Curr
Pharm Des. 2013;19:4893-4899.
24. Lee MJ, Yoon TG, Kang M, Kim HJ, Kang KS. Effect of subcutaneous treatment with human umbilical cord blood-derived multipotent stem cells on peripheral neuropathic pain in rats. Korean J
Physiol Pharmacol. 2017;21:153-160.
25. Park HW, Kim Y, Chang JW, Yang YS, Oh W, Lee JM, Park HR,
Kim DG, Paek SH. Effect of single and double administration of human umbilical cord blood-derived mesenchymal stem cells following focal cerebral ischemia in rats. Exp Neurobiol. 2017;26:55-65.
26. Yang SE, Ha CW, Jung M, Jin HJ, Lee M, Song H, Choi S, Oh W,
Yang YS. Mesenchymal stem/progenitor cells developed in cultures
from UC blood. Cytotherapy. 2004;6:476-486.
27. Olsen EA. Hair disorders. In: Irvine AD, Hoeger PH, Yan AC, editors. Harper’s textbook of pediatric dermatology. Volume 1, 2, 3rd
https://doi.org/10.4196/kjpp.2018.22.5.555

IGFBP-1 secreted by hUCB-MSCs enhances hair regrowth
ed. 2011. p.148.1-148.35.
28. Mounsey AL, Reed SW. Diagnosing and treating hair loss. Am Fam
Physician. 2009;80:356-362.
29. Cotsarelis G, Millar SE. Towards a molecular understanding of hair
loss and its treatment. Trends Mol Med. 2001;7:293-301.
30. Semenova E, Koegel H, Hasse S, Klatte JE, Slonimsky E, Bilbao
D, Paus R, Werner S, Rosenthal N. Overexpression of mIGF-1 in
keratinocytes improves wound healing and accelerates hair follicle
formation and cycling in mice. Am J Pathol. 2008;173:1295-1310.
31. Leirós GJ, Attorresi AI, Balañá ME. Hair follicle stem cell differentiation is inhibited through cross-talk between Wnt/β-catenin and
androgen signalling in dermal papilla cells from patients with androgenetic alopecia. Br J Dermatol. 2012;166:1035-1042.
32. Cardona-Gomez P, Perez M, Avila J, Garcia-Segura LM, Wandosell
F. Estradiol inhibits GSK3 and regulates interaction of estrogen
receptors, GSK3, and beta-catenin in the hippocampus. Mol Cell
Neurosci. 2004;25:363-373.
33. Armstrong DD, Wong VL, Esser KA. Expression of beta-catenin is
necessary for physiological growth of adult skeletal muscle. Am J
Physiol Cell Physiol. 2006;291:C185-188.
34. Dong L, Hao H, Xia L, Liu J, Ti D, Tong C, Hou Q, Han Q, Zhao Y,
Liu H, Fu X, Han W. Treatment of MSCs with Wnt1a-conditioned
medium activates DP cells and promotes hair follicle regrowth. Sci
Rep. 2014;4:5432.
35. Zheng Y, Du X, Wang W, Boucher M, Parimoo S, Stenn K. Organogenesis from dissociated cells: generation of mature cycling hair follicles from skin-derived cells. J Invest Dermatol. 2005;124:867-876.
36. Kang BM, Kwack MH, Kim MK, Kim JC, Sung YK. Sphere formation increases the ability of cultured human dermal papilla cells to
induce hair follicles from mouse epidermal cells in a reconstitution
assay. J Invest Dermatol. 2012;132:237-239.
37. Kwon TR, Oh CT, Choi EJ, Park HM, Han HJ, Ji HJ, Kim BJ. Human placental extract exerts hair growth-promoting effects through
the GSK-3β signaling pathway in human dermal papilla cells. Int J
Mol Med. 2015;36:1088-1096.
38. Iida M, Ihara S, Matsuzaki T. Hair cycle-dependent changes of alkaline phosphatase activity in the mesenchyme and epithelium in
mouse vibrissal follicles. Dev Growth Differ. 2007;49:185-195.
39. Lin TC, Yen JM, Gong KB, Hsu TT, Chen LR. IGF-1/IGFBP-1 increases blastocyst formation and total blastocyst cell number in
mouse embryo culture and facilitates the establishment of a stemcell line. BMC Cell Biol. 2003;4:14.
40. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995;16:3-34.
41. Baxter RC. Insulin-like growth factor (IGF) binding proteins: the
role of serum IGFBPs in regulating IGF availability. Acta Paediatr
Scand Suppl. 1991;372:107-114.
42. Shapiro J, Madani S. Alopecia areata: diagnosis and management. Int J Dermatol. 1999;38 Suppl 1:19-24.
43. Rushton DH, Norris MJ, Dover R, Busuttil N. Causes of hair loss
and the developments in hair rejuvenation. Int J Cosmet Sci.
2002;24:17-23.
44. Iguchi M, Hara M, Manome H, Kobayasi H, Tagami H, Aiba S.
Communication network in the follicular papilla and connective
tissue sheath through gap junctions in human hair follicles. Exp
Dermatol. 2003;12:283-288.
45. Hibino T, Nishiyama T. Role of TGF-beta2 in the human hair
www.kjpp.net

565
cycle. J Dermatol Sci. 2004;35:9-18.
46. Messenger AG. The control of hair growth: an overview. J Invest
Dermatol. 1993;101(1 Suppl):4S-9S.
47. Phinney DG. Biochemical heterogeneity of mesenchymal stem
cell populations: clues to their therapeutic efficacy. Cell Cycle.
2007;6:2884-2889.
48. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U,
Krause U, Blake J, Schwager C, Eckstein V, Ansorge W, Ho AD.
Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp
Hematol. 2005;33:1402-1416.
49. Anderson DG, Markova D, An HS, Chee A, Enomoto-Iwamoto M,
Markov V, Saitta B, Shi P, Gupta C, Zhang Y. Human umbilical cord
blood-derived mesenchymal stem cells in the cultured rabbit intervertebral disc: a novel cell source for disc repair. Am J Phys Med
Rehabil. 2013;92:420-429.
50. Liu GP, Li YL, Sun J, Cui L, Zhang WJ, Cao YL. Repair of calvarial
defects with human umbilical cord blood derived mesenchymal
stem cells and demineralized bone matrix in athymic rats. Zhonghua Zheng Xing Wai Ke Za Zhi. 2010;26:34-38.
51. Chen L, Tredget EE, Wu PY, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and
enhance wound healing. PLoS One. 2008;3:e1886.
52. Guo J, Lin GS, Bao CY, Hu ZM, Hu MY. Anti-inflammation role
for mesenchymal stem cells transplantation in myocardial infarction. Inflammation. 2007;30:97-104.
53. Xie Z, Hao H, Tong C, Cheng Y, Liu J, Pang Y, Si Y, Guo Y, Zang
L, Mu Y, Han W. Human umbilical cord-derived mesenchymal
stem cells elicit macrophages into an anti-inflammatory phenotype
to alleviate insulin resistance in type 2 diabetic rats. Stem Cells.
2016;34:627-639.
54. Arthur A, Zannettino A, Gronthos S. The therapeutic applications
of multipotential mesenchymal/stromal stem cells in skeletal tissue
repair. J Cell Physiol. 2009;218:237-245.
55. Davis ME, Hsieh PC, Takahashi T, Song Q, Zhang S, Kamm RD,
Grodzinsky AJ, Anversa P, Lee RT. Local myocardial insulin-like
growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl
Acad Sci U S A. 2006;103:8155-8160.
56. Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song
YH, Titterington J, Delafontaine P. IGF-1 reduces inflammatory
responses, suppresses oxidative stress, and decreases atherosclerosis
progression in ApoE-deficient mice. Arterioscler Thromb Vasc Biol.
2007;27:2684-2690.
57. Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh
KB. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1,
IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat
Metab Disord. 1997;21:355-359.
58. Weger N, Schlake T. Igf-I signalling controls the hair growth
cycle and the differentiation of hair shafts. J Invest Dermatol.
2005;125:873-882.
59. Toyoshima KE, Asakawa K, Ishibashi N, Toki H, Ogawa M, Hasegawa T, Irié T, Tachikawa T, Sato A, Takeda A, Tsuji T. Fully functional
hair follicle regeneration through the rearrangement of stem cells
and their niches. Nat Commun. 2012;3:784.
60. Rendl M, Polak L, Fuchs E. BMP signaling in dermal papilla cells
Korean J Physiol Pharmacol 2018;22(5):555-566

566
is required for their hair follicle-inductive properties. Genes Dev.
2008;22:543-557.
61. Zhou L, Yang K, Xu M, Andl T, Millar SE, Boyce S, Zhang Y. Activating β-catenin signaling in CD133-positive dermal papilla cells
increases hair inductivity. FEBS J. 2016;283:2823-2835.

Korean J Physiol Pharmacol 2018;22(5):555-566

Bak DH et al
62. Huang CF, Chang YJ, Hsueh YY, Huang CW, Wang DH, Huang
TC, Wu YT, Su FC, Hughes M, Chuong CM, Wu CC. Assembling
composite dermal papilla spheres with adipose-derived stem cells to
enhance hair follicle induction. Sci Rep. 2016;6:26436.

https://doi.org/10.4196/kjpp.2018.22.5.555

